Rodman & Renshaw Re-Initiates Coverage on DUSA Pharmaceuticals (DUSA) with a Market Outperform, Sees as Possible Takeover Target
Tweet Send to a Friend
Rodman & Renshaw re-initiates coverage on DUSA Pharmaceuticals (Nasdaq: DUSA) with a Market Outperform. Price target $6.
Rodman ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Rodman ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


